Cantitate/Preț
Produs

Multinational Pharmaceutical Firms'' FDI in China

Autor Fuming Jiang
de Limba Germană Paperback – 25 oct 2013
The opening-up of Chinese economy in 1978 and the subsequent reforms provided multinational corporations with tremendous opportunities to invest in and explore the world''s largest developing market. China, however, presents a complicated and difficult operating business environment for foreign investors. This PhD thesis demonstrates a comprehensive, multi-level study on 44 multinational pharmaceutical firms'' strategic planning and implementation of foreign direct investment (FDI) strategies in China during the first tweenty years of China''s open-door policy and economic reform era. The study developed an integrated master conceptual framework and examined a series of key issues related to the strategic FDI decision-making and implementation processes, including FDI determinants, entry mode choice between joint venture and wholly owned subsidiary, joint venture partners selection, FDI operating location choice within China, and the determinants of FDI effectiveness and success in China. The thesis received exemplary reports from all examiners, and the PhD candidate was awarded the "Research Achievement Prize" by Swinburne University.
Citește tot Restrânge

Preț: 48538 lei

Preț vechi: 52759 lei
-8% Nou

Puncte Express: 728

Preț estimativ în valută:
9289 9677$ 7723£

Carte tipărită la comandă

Livrare economică 08-22 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783639100396
ISBN-10: 3639100395
Pagini: 492
Dimensiuni: 153 x 223 x 33 mm
Greutate: 0.65 kg
Editura: VDM Verlag Dr. Müller e.K.

Notă biografică

Dr JIANG Fuming is a senior lecturer in the College of Business and Economics, Australian National University. He teaches international business and researches MNCs' FDI into and from China, and has published five books and sixteen articles in journals such as Journal of World Business, Journal of Business Strategies, Management Decision.